authors
- Hose, Dirk
- Seckinger, Anja
- Goldschmidt, Hartmut
- Meissner, Tobias
- Leber, Brian
- Neben, Kai
- Hillengass, Jens
- Bertsch, Uta
- Janssen, Bernd
- Klein, Bernard
- Lewis, Joe
- Vanderkerken, Karin
- Schultes, Christoph
A Novel Class of Sulfonanilides Entering Clinical Trials for Targeted Treatment of Multiple Myeloma: Dual-Mechanism Compounds Inhibiting HIF1A-Signaling and Inducing Apoptosis
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- November 19, 2010
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1114 Paediatrics and Reproductive Medicine (FoR)
- Immunology (Science Metrix)
published in
- Blood Journal